AAAAAA

   
Results: 1-8 |
Results: 8
UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN TISSUE AND SERUM OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA PATIENTS
Authors: STROJAN P BUDIHNA M SMID L VRHOVEC I SKRK J
Citation: P. Strojan et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) IN TISSUE AND SERUM OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA PATIENTS, European journal of cancer, 34(8), 1998, pp. 1193-1197
CONCOMITANT RADIOTHERAPY WITH MITOMYCIN-C AND BLEOMYCIN COMPARED WITHRADIOTHERAPY ALONE IN INOPERABLE HEAD AND NECK-CANCER - FINAL REPORT
Authors: ZAKOTNIK B SMID L BUDIHNA M LESNICAR H SOBA E FURLAN L ZARGI M
Citation: B. Zakotnik et al., CONCOMITANT RADIOTHERAPY WITH MITOMYCIN-C AND BLEOMYCIN COMPARED WITHRADIOTHERAPY ALONE IN INOPERABLE HEAD AND NECK-CANCER - FINAL REPORT, International journal of radiation oncology, biology, physics, 41(5), 1998, pp. 1121-1127
CATHEPSIN-D IN TISSUE AND SERUM OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: STROJAN P BUDIHNA M SMID L VRHOVEC I SKRK J
Citation: P. Strojan et al., CATHEPSIN-D IN TISSUE AND SERUM OF PATIENTS WITH SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Cancer letters, 130(1-2), 1998, pp. 49-56
PROGNOSTIC VALUE OF CATHEPSIN-B, CATHEPSIN-D AND STEFIN-A AND STEFIN-B IN LARYNGEAL CARCINOMA
Authors: SMID L STROJAN P BUDIHNA M SKRK J VRHOVEC I ZARGI M KOS J
Citation: L. Smid et al., PROGNOSTIC VALUE OF CATHEPSIN-B, CATHEPSIN-D AND STEFIN-A AND STEFIN-B IN LARYNGEAL CARCINOMA, European archives of oto-rhino-laryngology, 254, 1997, pp. 150-153
PROGNOSTIC VALUE OF CATHEPSIN-B, CATHEPSIN-H, CATHEPSIN-L, CATHEPSIN-D AND THEIR ENDOGENOUS INHIBITORS STEFIN-A AND STEFIN-B IN HEAD-AND-NECK-CARCINOMA
Authors: BUDIHNA M STROJAN P SMID L SKRK J VRHOVEC I ZUPEVC A RUDOLF Z ZARGI M KRASOVEC M SVETIC B KOPITARJERALA N KOS J
Citation: M. Budihna et al., PROGNOSTIC VALUE OF CATHEPSIN-B, CATHEPSIN-H, CATHEPSIN-L, CATHEPSIN-D AND THEIR ENDOGENOUS INHIBITORS STEFIN-A AND STEFIN-B IN HEAD-AND-NECK-CARCINOMA, Biological chemistry Hoppe-Seyler, 377(6), 1996, pp. 385-390
PROGNOSTIC VALUE OF TOTAL CATHEPSIN-B IN INVASIVE DUCTAL CARCINOMA OFTHE BREAST
Authors: BUDIHNA M SKRK J ZAKOTNIK B GABRIJELCIC D LINDTNER J
Citation: M. Budihna et al., PROGNOSTIC VALUE OF TOTAL CATHEPSIN-B IN INVASIVE DUCTAL CARCINOMA OFTHE BREAST, European journal of cancer, 31A(5), 1995, pp. 661-664
RADIOTHERAPY, COMBINED WITH SIMULTANEOUS CHEMOTHERAPY WITH MITOMYCIN-C AND BLEOMYCIN FOR INOPERABLE HEAD AND NECK-CANCER - PRELIMINARY-REPORT
Authors: SMID L LESNICAR H ZAKOTNIK B SOBA E BUDIHNA M FURLAN L ZARGI M RUDOLF Z
Citation: L. Smid et al., RADIOTHERAPY, COMBINED WITH SIMULTANEOUS CHEMOTHERAPY WITH MITOMYCIN-C AND BLEOMYCIN FOR INOPERABLE HEAD AND NECK-CANCER - PRELIMINARY-REPORT, International journal of radiation oncology, biology, physics, 32(3), 1995, pp. 769-775
CATHEPSIN-B, CATHEPSIN-H AND CATHEPSIN-L IN HUMAN BREAST-CARCINOMA
Authors: GABRIJELCIC D SVETIC B SPAIC D SKRK J BUDIHNA M DOLENC I POPOVIC T COTIC V TURK V
Citation: D. Gabrijelcic et al., CATHEPSIN-B, CATHEPSIN-H AND CATHEPSIN-L IN HUMAN BREAST-CARCINOMA, European journal of clinical chemistry and clinical biochemistry, 30(2), 1992, pp. 69-74
Risultati: 1-8 |